Bio-IT 2023
Bio-IT 2023, held May 16-18 in Boston, will showcase cutting-edge technologies and analytic methods advancing precision medicine, featuring presentations like Christian Olsen's on unified data platforms for biologics discovery, networking events with industry experts from Dotmatics and partners, and sessions on modern lab components and digital transformation in life sciences.
Bio-IT 2023 will feature technologies and analytic approaches that accelerate science and drive the future of precision medicine.
Event Details:
- Date: May 16-18, 2023
- Location: Boston, MA | Booth #612
Join leading experts in life sciences, pharmaceuticals, clinical research, healthcare, informatics, and technology at the Bio-IT World Conference & Expo. The event brings together professionals from biomedical research, drug discovery & development, and healthcare sectors worldwide.
Attend Our Presentation
Next-Gen Biologics—Harmonizing Science & Technology to Make the Right Decisions, Fast
Presenter: Christian Olsen, Dotmatics Associate Vice President, Industry Principal, Biology
Developing biologic therapeutics requires a series of successful decisions throughout the early discovery process. Common roadblocks in early discovery include highly fractured data silos and large volumes of data, which can cost investigators valuable time and money. Learn how leading biopharmaceutical companies are leveraging a unified, extensible, and open data software platform designed to harmonize science and data, enabling more efficient identification of pre-clinical candidates.
The Bio-IT Reception
During this customer appreciation reception, attendees will have the opportunity to meet peers, Dotmatics executives, and subject matter experts from Protein Metrics, SnapGene, and Geneious Biologics. Discussions will focus on the latest trends and advancements in the industry.
The Bio-IT Breakfast
At this breakfast session, attendees will hear from Brian Gilman, VP of Research Technology at Vertex Pharmaceuticals, and Kalim Saliba, Chief Product Officer of Dotmatics. Topics include:
- Key components of a modern lab
- Digital transformation without scientific disruption
- Data literacy within an organization
Meet Us at Bio-IT
Attendees are invited to schedule meetings during the event.
Featured Speakers:
- Christian Olsen, VP Strategy, Protein Therapeutics, Luma
Event Details:
- May 16-18, 2023
- 7:00 am
- Boston, MA | Booth #612
Related
Next Generation Biologics R&D
Christian Olsen of Dotmatics highlighted at the BioIT-World Expo how their flexible end-to-end R&D platform overcomes challenges in biologics discovery—such as fragmented, diverse, and siloed data from multiple complex analytical methods like sequencing, mass spectrometry, and flow cytometry—by unifying data and tools to enable multidimensional candidate profiling, streamline workflows, and accelerate preclinical biologics research.
Bio-IT World
Dotmatics will be exhibiting at BioIT World 2024 in Boston from April 15-17 at Booth #315, featuring expert discussions on new product launches and enhancements, including a presentation by Christian Olsen, AVP of Biologics, on April 16th about Luma and its lab applications.
Dotmatics Customer Symposium (Cambridge, UK)
The Dotmatics Customer Symposium, a two-day in-person event at the Wellcome Genome Campus in Cambridge, UK, on October 13-14, 2022, features presentations from Dotmatics leadership and customers, workshops, panel discussions, and networking opportunities focused on scientific R&D areas such as Small Molecule and Biologics Discovery, Formulations Innovation, product integrations, and the future vision of Dotmatics products.
Optimizing Bial’s Life-Changing Drug R&D
Bial, a biopharmaceutical leader in neuroscience and rare diseases, overcame fragmented software and collaboration challenges by adopting Dotmatics' unified SaaS platform, which streamlined R&D workflows, enhanced data accessibility, reduced IT complexity, and enabled researchers to focus on developing life-changing treatments.
From Fragmented Data to Unified Discovery: LifeArc's Approach to Multimodal R&D
LifeArc, a UK-based medical charity focused on transformative life science, has developed a collaborative, multidisciplinary R&D approach that integrates diverse data from over 100 internal scientists, external pharma, biotech, academic partners, and CROs across multiple therapeutic modalities—including small molecules and biologics like engineered antibodies—to streamline drug discovery and design for diseases such as cancer, Crohn’s disease, multiple sclerosis, rheumatoid arthritis, and COVID-19, enabling unified data flow and informed, data-driven decision-making that has already resulted in four licensed medications and several drugs in trials.
Dotmatics Launches BioGlyph Luma to Accelerate the Future of Protein Design & Engineering
Dotmatics has launched BioGlyph Luma, a next-generation protein design and engineering solution integrated into its Luma Scientific Intelligence Platform, which addresses the Design phase of the protein therapeutics research cycle by enabling real-time traceability, scalable registration, and seamless integration with existing scientific tools to accelerate multimodal biologic R&D workflows with precision and data-driven automation.